| Number of Reports | Cross-Linked | Molecular Weight Category | Injections | Compare |
|---|---|---|---|---|
|
SYNVISC
18
Sanofi
Canada, United States
|
Yes | High | ≤3 | |
|
SYNVISC-ONE
1
Sanofi
Canada, United States
|
Yes | High | ≤3 | |
|
DUROLANE
5
Bioventus
Canada
|
Yes | High | ≤3 | |
|
EUFLEXXA
3
Bio-Technology General (Israel) Ltd.
Canada, United States
|
No | High | ≤3 | |
|
Gel-One
1
Seikagaku Corporation
United States
|
Yes | High | ≤3 | |
|
Monovisc
0
Anika Therapeutics, Inc.
Canada, United States
|
Yes | Moderate | ≤3 | |
|
Orthovisc
7
Anika Therapeutics, Inc.
Canada, United States
|
No | Moderate | ≤3 | |
|
Hyalgan
22
Fidia Farmaceutici S.p.a.
Canada, United States
|
No | Low | >3 | |
|
SUPARTZ
7
Seikagaku Corporation
United States
|
No | Low | >3 | |
|
GenVisc 850
2
Tedec-Meiji Farma, S.A.
United States
|
No | Low | >3 | |
|
Gel-Syn
1
Institut Biochimique S.A. (IBSA)
United States
|
No | Low | ≤3 | |
|
SUPLASYN
1
Bioniche Teoranta
Canada
|
No | Low | ≤3 | |
|
HYMOVIS
0
Fidia Farmaceutici S.p.a.
United States
|
No | Low | ≤3 | |
|
NeoVisc
0
Aralez Pharmaceuticals Inc.
Canada
|
No | Low | ≤3 |